Alison J. Gibbs

Alison J. Gibbs

Auto-generated profile, based on publicly available information

Alison J. Gibbs

La Trobe Sports and Exercise Medicine Research Centre, La Trobe University, Bundoora, Australia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2023 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
AGAlison J. Gibbs
Alison J. Gibbs
BGBimbi Gray
Bimbi Gray
JWJason A. Wallis
Jason A. Wallis
NTNicholas F. Taylor
Nicholas F. Taylor
JKJoanne L. Kemp
Joanne L. Kemp
CBChristian J. Barton
Christian J. Barton

11 April 2022 in Musculoskeletal Care
Verified
Journal Article
Open access
AGAlison J. Gibbs
Alison J. Gibbs
JWJason A. Wallis
Jason A. Wallis
NTNicholas F. Taylor
Nicholas F. Taylor
JKJoanne L. Kemp
Joanne L. Kemp
CBChristian J. Barton
Christian J. Barton
Objective: Hip and knee osteoarthritis guidelines internationally provide consistent first‐line care recommendations. However, uptake of these recommendations remains suboptimal. This qualitative study explores factors influencing guideline‐based care from the perspectives of physiotherapists working in specialised osteoarthritis services across different models of care.Methods: Nineteen semi‐structured interviews were conducted with physiotherapists working in specialist osteoarthritis services across three different Australian models of care (OsteoArthritis Hip and Knee Service n = 10; OsteoArthritis Chronic Care Programme n = 4; Orthopaedic Physiotherapy Screening Clinics and Multidisciplinary Services n = 5). Interviews were audio recorded and transcribed verbatim. Data were coded and analysed inductively using thematic analysis.Results: The overarching theme to emerge was that accessing first‐line osteoarthritis care is complex and difficult, regardless of model of care. Subthemes indicated that: (i) services are either unavailable or inadequately funded, (ii) referral pathways are labyrinthine and lengthy, (iii) patients and other health professionals often believe that surgery is the only/best option and (iv) managing patient co‐morbidities is challenging.Conclusion: Physiotherapists working in specialised osteoarthritis services perceive multiple and complex factors influencing adherence to first‐line care. Barriers occur at various levels in all models of care, including patient and health professional beliefs, health service, and system levels. These results suggest improving healthcare for people with osteoarthritis requires urgent system reform.

5 March 2024 in Osteoarthritis and Cartilage
Verified
Journal Article
Open access
BGBimbi Gray
Bimbi Gray
AGAlison Gibbs
Alison Gibbs
JBJocelyn L. Bowden
Jocelyn L. Bowden
JEJillian Peta Eyles
Jillian Peta Eyles
SGSandra Grace
Sandra Grace
DHDavid Hunter
David Hunter
Clinical Practice Guidelines (CPGs) aim to support management of hip and knee osteoarthritis (OA), but recommendations are often conflicting and implementation is poor, contributing to evidence-to-practice gaps. This systematic review investigated the contextual and methodological factors contributing to conflicting recommendations for hip and knee OA. Our systematic review appraised CPGs for managing hip and knee OA in adults ≥18 years (PROSPERO CRD42021276635). We used AGREE-II and AGREE-REX to assess quality and extracted data on treatment gaps, conflicts, biases, and consensus. Heterogeneity of recommendations was determined using Weighted Fleiss Kappa (K). The relationship between (K) and AGREE-II/AGREE-REX scores was explored. We identified 25 CPGs across eight countries and four international organisations. The ACR, EULAR, NICE, OARSI and RACGP guidelines scored highest for overall AGREE-II quality (83%). The highest overall AGREE-REX scores were for BMJ Arthroscopy (80%), RACGP (78%) and NICE (76%). CPGs with the least agreement for pharmacological recommendations were ESCEO and NICE (-0.14), ACR (-0.08), and RACGP (-0.01). The highest agreements were between RACGP and NICE (0.53), RACGP and ACR (0.61), and NICE and ACR (0.91). Decreased internal validity determined by low-quality AGREE scores(<60%) in editorial independence were associated with less agreement for pharmacological recommendations. There were associations between guideline quality and agreement scores. Future guideline development should be informed by robust evidence, editorial independence and methodological rigour to ensure a harmonisation of recommendations. End-users of CPGs must recognise the contextual factors associated with the development of OA CPGs and balance these factors with available evidence.

19 December 2024 in BMC Primary Care
Verified
Journal Article
Open access
PDF file
AGAlison J. Gibbs
Alison J. Gibbs
CBChristian J. Barton
Christian J. Barton
NTNicholas F. Taylor
Nicholas F. Taylor
JKJoanne L. Kemp
Joanne L. Kemp
JWJason A. Wallis
Jason A. Wallis
AEAllison M. Ezzat
Allison M. Ezzat
Background: General practitioners (GPs) play a key role in managing osteoarthritis, including referring to appropriate management services. Physiotherapist-led osteoarthritis management programs and advanced practice triage services are effective, but GPs views on them are largely unknown. This study aimed to explore general practitioner perspectives on: (1) managing patients with hip and knee osteoarthritis, and (2) physiotherapy-led osteoarthritis care and referral pathways. Methods: Interview topic guides were developed based on the theoretical domains framework. Twenty-five semi-structured interviews with GPs were conducted. All data were coded independently by at least two researchers and analysed inductively using thematic analysis, with barrier themes mapped to the socioecological model. Results: Two interrelated themes were identified: (i) GPs had good general knowledge of recommended osteoarthritis care, but (ii) they faced multi-level challenges facilitating or directly providing evidence-based care. Nearly all GPs identified exercise as first-line care and surgery as a last resort. Most were aware imaging was not required to diagnose osteoarthritis, yet reported often referring for imaging. Many GPs expressed challenges facilitating patient engagement in physiotherapy due to patient, environmental/social and system level barriers. Key barriers included: perceived patient expectations and lack of motivation to attend physiotherapy, a lack of knowledge of available physiotherapy services, a lack of affordable physiotherapy services, and lengthy waiting times for public orthopaedic appointments. Having private health insurance was perceived as an enabler. Conclusions: Despite having good knowledge of guideline-recommended care, GPs in our study experienced multi-level barriers to implementing this care in practice. Public health information and strategies to address patient’s beliefs and lack of motivation to exercise may help reduce barriers to engaging in appropriate care. Urgent health system funding reforms are needed to allow GPs to appropriately manage patients with hip and knee osteoarthritis.

21 November 2023 in BMJ Open
Verified
Journal Article
Open access
PDF file
EBEmily Catherine Bell
Emily Catherine Bell
POPaul O'HAlloran
Paul O'HAlloran
JWJason A Wallis
Jason A Wallis
KCKay M Crossley
Kay M Crossley
AGAlison J Gibbs
Alison J Gibbs
CBChristian J Barton
Christian J Barton
Objective The objective of this study was to determine the feasibility and effectiveness of using SUpported Motivational InTerviewing (SUMIT) to increase physical activity in people with knee osteoarthritis (KOA). Design Randomised controlled trial. Setting We recruited people who had completed Good Life with osteoArthritis Denmark (GLA:D) from private, public and community settings in Victoria, Australia. Interventions Participants were randomised participants to receive SUMIT or usual care. SUMIT comprised five motivational interviewing sessions targeting physical activity over 10 weeks, and access to a multimedia web-based platform. Participants Thirty-two participants were recruited (17 SUMIT, 15 control) including 22 females (69%). Outcome measures Feasibility outcomes included recruitment rate, adherence to motivational interviewing, ActivPAL wear and drop-out rate. Effect sizes (ESs) were calculated for daily steps, stepping time, time with cadence >100 steps per minute, time in bouts >1 min; 6 min walk distance, Knee Osteoarthritis Outcome Score (KOOS) subscales (pain, symptoms, function, sport and recreation, and quality of life (QoL)), Euroqual, systolic blood pressure, body mass index, waist circumference, 30 s chair stand test and walking speed during 40 m walk test. Results All feasibility criteria were achieved, with 32/63 eligible participants recruited over seven months; with all participants adhering to all motivational interviewing calls and achieving sufficient ActivPAL wear time, and only two drop-outs (6%). 12/15 outcome measures showed at least a small effect (ES>0.2) favouring the SUMIT group, including daily time with cadence >100 steps per minute (ES=0.43). Two outcomes, walking speed (ES= 0.97) and KOOS QoL (ES=0.81), showed a large effect (ES>0.8). Conclusion SUMIT is feasible in people with knee osteoarthritis. Potential benefits included more time spent walking at moderate intensity, faster walking speeds and better QoL. Trial registration number ACTRN12621000267853.

3 March 2026 in Osteoarthritis and Cartilage
Verified
Journal Article
Open access
JLJuanita Low
Juanita Low
DSDanilo De Oliveira Silva
Danilo De Oliveira Silva
AEAllison M. Ezzat
Allison M. Ezzat
AGAlison J. Gibbs
Alison J. Gibbs
LSLarissa Rodrigues Souto
Larissa Rodrigues Souto
CBChristian J. Barton
Christian J. Barton
Knee osteoarthritis affects millions globally, and understanding characteristics of participants included in randomised controlled trials (RCTs) that inform current treatment recommendations is required to assess their global applicability. We aimed to comprehensively describe the sociodemographic and clinical characteristics of participants reported in knee osteoarthritis RCTs of first-line care. Nine databases, guideline repositories, and professional associations' websites were searched from inception to March 2025 for higher-quality systematic reviews (determined by A MeaSurement Tool to Assess systematic Reviews-2) and clinical practice guidelines (CPGs) (determined by Appraisal of Guidelines for Research and Evaluation II). Sociodemographic (guided by the PROGRESS-Plus framework) and clinical characteristics reported in RCTs included within these systematic reviews and CPGs were extracted and summarised descriptively. PROSPERO #CRD42023463878. We included 241 RCTs involving 22,443 participants, representing 17% of countries (34/198). 95% (n=229/241) were of moderate-to-high quality (PEDro). 55% (n=133/241) were from high-income countries. None were from low-income countries. No RCTs originated from Eastern Europe, Central Asia, the Caribbean, East and Central Africa, Melanesia, Micronesia, nor Polynesia. Most sociodemographic variables were reported in less than 15% of RCTs, including residence (2%, n=6), primary language (0%, n=0), employment (14%, n=33) and socioeconomic status (7%, n=17). Only 15% (n=36) of RCTs reported race/ethnicity; of which 32 originated from the United States. Reporting of sociodemographic variables did not improve over time. Randomised controlled trial participants were typically older (average=63 years), white women/female, tertiary educated, overweight (average BMI=30 kg/m2), multimorbid (range=2-14 comorbidities), and experiencing moderate pain (average=58/100). Limited reporting and global population representation in knee osteoarthritis RCTs reduces applicability of findings, undermines treatment recommendations, and risks exacerbating existing global health inequities. Addressing reporting and representation blind spots is urgently needed in RCTs informing first-line care for knee osteoarthritis.